CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 27,350
-550 (-1.97%)
At close: Aug 4, 2025, 3:30 PM KST
Perficient Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
Operating Revenue | 2,568 | 2,290 | 1,471 | 1,763 | 916.88 | 1,361 | Upgrade |
Other Revenue | - | -0 | - | - | - | - | Upgrade |
| 2,568 | 2,290 | 1,471 | 1,763 | 916.88 | 1,361 | Upgrade | |
Revenue Growth (YoY) | 94.14% | 55.64% | -16.54% | 92.27% | -32.61% | 288.80% | Upgrade |
Cost of Revenue | 1,566 | 1,327 | 1,162 | 1,559 | 1,044 | 1,339 | Upgrade |
Gross Profit | 1,003 | 963.28 | 309.04 | 203.57 | -126.94 | 21.62 | Upgrade |
Selling, General & Admin | 2,188 | 2,099 | 1,263 | 2,443 | 2,017 | 1,619 | Upgrade |
Research & Development | 5,397 | 5,295 | 3,426 | 2,976 | 2,340 | 1,403 | Upgrade |
Other Operating Expenses | 129.81 | 118.08 | 92.58 | 87.86 | 66.61 | 56.73 | Upgrade |
Operating Expenses | 8,326 | 8,100 | 5,352 | 5,507 | 4,423 | 3,079 | Upgrade |
Operating Income | -7,324 | -7,137 | -5,043 | -5,303 | -4,550 | -3,057 | Upgrade |
Interest Expense | -118.38 | -129.87 | -140.18 | -352.51 | -276.8 | -137.02 | Upgrade |
Interest & Investment Income | 555.72 | 363.22 | 74.81 | 124.2 | 36.07 | 13.28 | Upgrade |
Currency Exchange Gain (Loss) | 0.54 | -0.92 | - | -0.13 | 0.01 | -0.04 | Upgrade |
Other Non Operating Income (Expenses) | -414.43 | -363.18 | 202.5 | -1,014 | 13.34 | 141.89 | Upgrade |
EBT Excluding Unusual Items | -7,301 | -7,267 | -4,906 | -6,546 | -4,778 | -3,039 | Upgrade |
Gain (Loss) on Sale of Assets | 1.27 | 1.29 | 9.89 | - | -0 | - | Upgrade |
Other Unusual Items | - | - | 1,263 | 164.1 | - | - | Upgrade |
Pretax Income | -7,299 | -7,266 | -3,633 | -6,382 | -4,778 | -3,039 | Upgrade |
Net Income | -7,299 | -7,266 | -3,633 | -6,382 | -4,778 | -3,039 | Upgrade |
Net Income to Common | -7,299 | -7,266 | -3,633 | -6,382 | -4,778 | -3,039 | Upgrade |
Shares Outstanding (Basic) | 13 | 10 | 10 | 10 | 9 | 9 | Upgrade |
Shares Outstanding (Diluted) | 13 | 10 | 10 | 10 | 9 | 9 | Upgrade |
Shares Change (YoY) | - | 2.34% | 2.22% | 10.36% | 1.48% | 0.97% | Upgrade |
EPS (Basic) | -570.21 | -715.78 | -366.24 | -657.64 | -543.34 | -350.74 | Upgrade |
EPS (Diluted) | -570.21 | -715.78 | -366.24 | -658.00 | -543.34 | -351.00 | Upgrade |
Free Cash Flow | -5,562 | -4,904 | -4,240 | -5,074 | -3,572 | -2,380 | Upgrade |
Free Cash Flow Per Share | -434.46 | -483.08 | -427.43 | -522.88 | -406.23 | -274.73 | Upgrade |
Gross Margin | 39.04% | 42.07% | 21.00% | 11.55% | -13.84% | 1.59% | Upgrade |
Operating Margin | -285.19% | -311.67% | -342.79% | -300.83% | -496.28% | -224.69% | Upgrade |
Profit Margin | -284.22% | -317.32% | -246.92% | -362.02% | -521.08% | -223.36% | Upgrade |
Free Cash Flow Margin | -216.56% | -214.16% | -288.18% | -287.84% | -389.58% | -174.95% | Upgrade |
EBITDA | -6,678 | -6,512 | -4,426 | -4,944 | -3,900 | -2,381 | Upgrade |
EBITDA Margin | -260.02% | -284.37% | - | -280.44% | - | -175.00% | Upgrade |
D&A For EBITDA | 646.37 | 625.05 | 617.69 | 359.53 | 650.52 | 676.09 | Upgrade |
EBIT | -7,324 | -7,137 | -5,043 | -5,303 | -4,550 | -3,057 | Upgrade |
EBIT Margin | -285.19% | - | - | - | - | -224.69% | Upgrade |
Advertising Expenses | - | 5.27 | 6.23 | 7.57 | 7.85 | 3.77 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.